Open company graph database — free web & API
Login

Tokyo Clinical Pharmacology Institute Inc.

株式会社東京臨床薬理研究所Tokyo Research Center of Clinical Pharmacology Co.,Ltd.Alias
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
12
§01

Basic information

BASIC
Head office
20 Sakamotocho, Yotsuya Medical Building, Shinjuku, Tokyo 160-0017
Chief executive
Akio Nakajima
Capital
401,875,000  (4 100 million)
Employees (non-consolidated)
Employees (consolidated)
Start date
1993-01-01
End date
§02

Websites

1 DOMAINS
§03

Business

4
Support for Clinical Trial OfficeSupport for Clinical Trial Review Board OfficeCRC (Clinical Research Coordinator) ServicesSubject Recruitment Support
§04

Related companies

12 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Shinano Medical Corporation
Group
Shinryo Reheat Industrial Co., Ltd.
Alliance
Shinano-kai Medical Corporation Shinano-zaka Clinic
医療法人社団信濃会 左門町クリニック
日本SMO協会
早稲田クリニック
Tokyo Musashino Hospital (General Foundation)
Tokai Capsule Co., Ltd.
東邦ホールディングスグループ
Toho Holdings Co., Ltd.
Shareholder
Medisel Research Institute Inc.
清瀬上宮病院
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

19 EVENTS

Founded in 1975 (Showa 50), the predecessor of the current Tokyo Clinical Pharmacology Research Institute Co., Ltd., Medisel Research Institute Co., Ltd., was established.Sources

Established in 1976, Medisel Research Institute Co., Ltd.Sources

Establishment of Medisel Research Institute Co., Ltd.Sources

In 1978 (Showa 53), the headquarters moved to Nishi-Ikebukuro, Toshima-ku, the institute expanded, and we began independent formulation development.Sources

In 1978 (Showa 53), the headquarters moved to Nishi-Ikebukuro, Toshima-ku, the institute expanded, and we began independent formulation development. With the cooperation of Tokai Capsule Co., Ltd., we succeeded in improving rectal absorption using Sott gelatin rectal capsules and applied for three patents.Sources

In 1981 (Showa 56), following the amendment of the Pharmaceutical Affairs Law, we began contracting bioequivalence studies targeting healthy adults. We partnered with Kiyose Kamiyama Hospital and Tokyo Musashino Hospital.Sources

In 1981 (Showa 56), following the amendment of the Pharmaceutical Affairs Law, we began contracting bioequivalence studies targeting healthy adults. We partnered with Kiyose Kamiyama Hospital and Tokyo Musashino Hospital.Sources

In 1984 (Showa 59), Hōkawa Clinic (a clinical trial specialty medical institution) was opened in Komagome with 18 beds, followed by the establishment of Hōkawa Second Clinic with 10 beds.Sources

In 1986 (Showa 61), Hōkawa Clinic with 10 beds was opened in Komagome, and our training center was established in Komoro, Nagano Prefecture.Sources

In 1987 (Showa 62), Hōkawa Clinic became independent. In 1988 (Showa 63), Waseda Clinic, a clinical trial specialty medical institution, was completed in Takada, Toshima-ku, and Medisel Research Institute Co., Ltd. fully supported Waseda Clinic to advance clinical trials.Sources

In 1987 (Showa 62), Hōkawa Clinic became independent.Sources

Separated and became independent from the Houkawa Clinic in 1987 (Showa 62).Sources

In 1988 (Showa 63), Waseda Clinic, a clinical trial specialty medical institution, was completed in Takada, Toshima-ku, and Medisel Research Institute Co., Ltd. fully supported Waseda Clinic to advance clinical trials.Sources

In 1988 (Showa 63), Waseda Clinic, a clinical trial specialty medical institution, was completed in Takada, Toshima-ku, and Medisel Research Institute Co., Ltd. fully supported Waseda Clinic to advance clinical trials.Sources

In 1993 (Heisei 5), with investment from Tōhō Pharmaceutical Co., Ltd. (now Tōhō Holdings Co., Ltd.) and others, Medisel Research Institute Co., Ltd. was dissolved, and Tokyo Clinical Pharmacology Research Institute Co., Ltd. was established.Sources

In 2003, the CRO division of Tokyo Clinical Pharmacology Research Institute Co., Ltd. was spun off and made independent, while SMO operations were expanded within Tokyo Clinical Pharmacology Research Institute Co., Ltd.Sources

The CRO division of Tokyo Clinical Pharmacology Research Institute Co., Ltd. was spun off and became independent, and SMO operations were carried out at Tokyo Clinical Pharmacology Research Institute Co., Ltd.Sources

In 2004, relocated to Yotsuya Medical Building.Sources

Relocated to Yotsuya Medical Building.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information7011101037551
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
株式会社東京臨床薬理研究所
Trade name (kana)
トウキョウリンショウヤクリケンキュウジョ
Name in English
Corporation type
301
Address
〒160-0017 東京都新宿区左門町20番地
Postal code
1600017
Prefecture code
13
City code
104
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2023-06-27
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
2248285
METI gBizINFO7011101037551
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
7011101037551
Trade name
株式会社東京臨床薬理研究所
Trade name (kana)
トウキョウリンショウヤクリケンキュウジョ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都新宿区左門町20番地
Postal code
1600017
Prefecture
東京都
Prefecture code
13
City or district
新宿区
City code
104
Street address
左門町20番地
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2023-06-27
Key information
7011101037551
§09

Sources & updates

SOURCES
↑